ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics Announces Key Additions to Scientific Advisory Board
Published in Vaccine Weekly, December 30th, 2009
ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced that it has appointed three new members, Colonel George Peoples, M.D. Director of the Cancer Vaccine Development Program and Deputy Director of the United States Military Cancer Institute (USMCI), Dr. Constantine Ioannides, Professor of Immunology at the M.D. Anderson Cancer Center, and Dr. Cohava Gelber, Chief Scientific & Technology Officer of ATCC to its Scientific Advisory Board. The recommendations were made with the strong support of the Company's Board of Directors, who cited these individuals' impressive research...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-12-30)
More Articles from Vaccine Weekly
- Rockefeller University Press
Hindering HIV-1-fighting immune cells - Thomas Jefferson University
Research reveals further progress toward AIDS vaccine - Adenovirus
Reports summarize adenovirus research from Vrije University Amsterdam - Bristol-Myers Squibb Company and Pfizer
Bristol-Myers Squibb and Pfizer Announce Plans To Submit Regulatory Filing for Apixaban In Europe - Candidiasis
New candidiasis data have been reported by researchers at University of Sao Paulo - Immunization
Research from University of Alabama provide new insights into immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
